In recent years, scientists have made great progress in implantable device research. In June 2015, the Harvard research team released an injectable mesh that detects electrical signals in the brain of mice. Help scientists understand how brain cells communicate, and the mesh is implanted into the brain through a needle that is only 0.1 mm in diameter. In a previous study published in the international journal Nature Communications, scientists from the United States created a tiny stent implant that helps capture cancer cells that spread in the body. . In this article, Xiaobian has taken a lot of research, let us look at how implantable devices can improve human health. [1]Science Supplement: Implantable ultrasound device helps chemotherapy drugs reach the tumor through the blood-brain barrier Recently, scientists from France developed an ultrasound device and tested experimental devices on 15 relapsed glioblastoma patients. The scientists developed the device to break through the blood-brain barrier and help chemotherapy drugs reach the brain. The relevant research results were published in the international academic journal Science Translational Medicine. The researchers explained how the ultrasound device works: implanting the device into the patient's skull, located above the tumor area, and the ultrasound causes the microbubble to vibrate briefly to open the blood-brain barrier, which helps the chemotherapy drug reach the tumor site. The ultrasound device needs to be turned on before each chemotherapy, and low-intensity ultrasound for two minutes is enough to open the blood-brain barrier for about six hours, which can increase the drug concentration by five to seven times. In this study, the researchers used the chemotherapy drug carboplatin for testing, and each patient was given an experimental treatment every month for up to six months, during which the tumor progression was tested. [2] Still taking a needle to measure blood sugar? Senseonics has to implant the blood glucose meter into the body. According to the 2020 Health and Life Science Trend Report released by Deloitte in 2014, diabetes may become the most common chronic disease in China by 2020. Global diabetes patients will reach 382 million. This shows that blood glucose monitoring has always been a global need. Recently, medical device company Senseonics made significant progress in blood glucose monitoring: its developed subcutaneous implantable blood glucose monitoring system Eversense Continuous Glucose Monitoring (CGM) passed the CE certification of the European Union management, which means that this system can be Widespread in Europe. CEO Dr. Tim Goodnow said: “Acquiring CE certification is a major affirmation for Senseonics, which means that our products will be sold and promoted among EU countries, and we also plan to use this system to benefit people with diabetes.†The main principle of the Eversense system is to implant the sensor under the skin of the patient's upper arm for a period of 90 days. Folding Half Face Mask,Disposable Face Cover for Self Use,Medical Kn95 Face Mask,Anti-fog Haze Dust Proof Face Dongguan Keyutai Mask Co., Ltd. , https://www.maskkytai.com.jpg)
.jpg)